Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Yin, Jun ^a   Wang, Xu ^a   Zheng, Liang ^b   Shi, Yijun ^a   Wang, Liming ^a   Shao, Aizhong ^a   Tang, Weifeng ^a   Ding, Guowen ^a   Liu, Chao ^a   Liu, Ruiping ^c   Chen, Suocheng ^a   Gu, Haiyong ^a  

^a JIANGSU UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c THE AFFILIATED CHANGZHOU NO 2 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; MICRORNA; MICRORNA 34B; MICRORNA 34C; MICRORNA 423; THYMINE; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHINESE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK PATIENT; HOSPITAL BASED CASE CONTROL STUDY; HSA MIR 34B GENE; HSA MIR 34C GENE; HSA MIR 423 GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POPULATION GENETICS; POPULATION RESEARCH; PRE MIR 125A GENE; PRI MIR 124 GENE; RISK REDUCTION; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84896700473     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080570     Document Type: Article

References (28)

1. Sand M, Gambichler T, Sand D, Skrygan M, Altmeyer P, et al. (2009) MicroRNAs and the skin: tiny players in the body's largest organ. J Dermatol Sci 53: 169-175.
2. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114.
3. Garzon R, Calin GA, Croce CM (2009) MicroRNAs in Cancer. Annu Rev Med 60: 167-179.
4. Shen H, Jin G (2013) Human genome epidemiology, progress and future. J Biomed Res 27: 167-169.
5. Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, et al. (2010) Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res 70: 2789-2798.
6. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, et al. (2007) p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17: 1298-1307. (Pubitemid 47176893)
7. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, et al. (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68: 4123-4132.
8. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J (2008) Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68: 2094-2105. (Pubitemid 351521781)
9. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, et al. (2007) Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67: 1424-1429. (Pubitemid 46383366)
10. Son MS, Jang MJ, Jeon YJ, Kim WH, Kwon CI, et al. (2013) Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma. Gene 524: 156-160.
11. Li L, Wu J, Sima X, Bai P, Deng W, et al. (2013) Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Tumour Biol 34: 1919-1923.
12. Han Y, Pu R, Han X, Zhao J, Zhang Y, et al. (2013) Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk. PLoS One 8: e58564.
13. Gao LB, Li LJ, Pan XM, Li ZH, Liang WB, et al. (2013) A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer. Biol Chem 394: 415-420.
14. Bensen JT, Tse CK, Nyante SJ, Barnholtz-Sloan JS, Cole SR, et al. (2013) Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study. Cancer Causes Control 24: 1099-1109.
15. Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, et al. (2008) Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res 68: 2530-2537. (Pubitemid 351521830)
16. Ye Y, Wang KK, Gu J, Yang H, Lin J, et al. (2008) Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res (Phila) 1: 460-469.
17. Peterlongo P, Caleca L, Cattaneo E, Ravagnani F, Bianchi T, et al. (2011) The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and Spain. J Med Genet 48: 703-704.
18. Smith RA, Jedlinski DJ, Gabrovska PN, Weinstein SR, Haupt L, et al. (2012) A genetic variant located in miR-423 is associated with reduced breast cancer risk. Cancer Genomics Proteomics 9: 115-118.
19. Xing J, Wan S, Zhou F, Qu F, Li B, et al. (2012) Genetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer. Cancer Epidemiol Biomarkers Prev 21: 217-227.
20. Wei J, Zheng L, Liu S, Yin J, Wang L, et al. (2013) MiR-196a2 rs11614913 T>C polymorphism and risk of esophageal cancer in a Chinese population. Hum Immunol 74: 1199-1205.
21. Gu H, Ding G, Zhang W, Liu C, Chen Y, et al. (2012) Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population. Mol Biol Rep 39: 9105-9111.
22. Chen ZJ, Zhao H, He L, et al (2011) Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 43: 55.
23. Mathe E, Nguyen GH, Funamizu N, He P, Moake M, et al. (2012) Inflammation regulates microRNA expression in cooperation with p53 and nitric oxide. Int J Cancer 131: 760-765.
24. Vogt M, Munding J, Gruner M, Liffers ST, Verdoodt B, et al. (2011) Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch 458: 313-322.
25. He L, He X, Lim LP, de Stanchina E, Xuan Z, et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134. (Pubitemid 47014436)
26. He L, He X, Lowe SW, Hannon GJ (2007) microRNAs join the p53 network - another piece in the tumour-suppression puzzle. Nat Rev Cancer 7: 819-822. (Pubitemid 350006254)
27. Kim NH, Kim HS, Kim NG, Lee I, Choi HS, et al. (2011) p53 and microRNA-34 are suppressors of canonical Wnt signaling. Sci Signal 4: ra71.
28. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H (2007) Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci U S A 104: 15472-15477. (Pubitemid 47502941)